Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIα gene

被引:30
作者
Falck, J
Jensen, PB
Sehested, M
机构
[1] Rigshosp, Dept Pathol, Lab Ctr, DK-2100 Copenhagen, Denmark
[2] Rigshosp, Finsen Ctr, Dept Oncol, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1074/jbc.274.26.18753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of DNA topoisomerase II alpha (topo II alpha) is cell cycle-regulated at both the transcriptional and the post- transcriptional levels. In order to identify cis-acting elements responsible for transcriptional regulation during the cell cycle, we investigated NIH/3T3 cells stably transfected with luciferase reporter plasmids containing various lengths of the human topo II alpha gene promoter. Serum-deprived cells expressed low levels of luciferase, and following serum-induced cell cycle reentry luciferase levels were gradually elevated 2-fold. During S phase, a steep S-fold increase in luciferase activity was seen, reaching its maximum approximately 22 h after serum addition. This pattern was observed with both a full-length (nucleotides (nt) -295 to +90] and a deletion (nt -90 to +90) promoter construct. In contrast, when testing a deletion construct (nt -51 to +90) lacking the first inverted CCAAT box (ICB1) the S phase-specific induction was absent. Mutation of ICB1 revealed that it had a repressive character, since luciferase levels rose rapidly to maximal levels immediately following serum addition. Furthermore, electrophoretic mobility shift assays demonstrated a marked decrease in ICB1 binding activity following serum addition. Together, this suggests a role of ICB1 in cell cycle-dependent repression of topo II alpha transcription.
引用
收藏
页码:18753 / 18758
页数:6
相关论文
共 39 条
[11]  
FRASER DJ, 1995, MOL PHARMACOL, V47, P696
[12]   The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIα gene by heat shock [J].
Furukawa, M ;
Uchiumi, T ;
Nomoto, M ;
Takano, H ;
Morimoto, RI ;
Naito, S ;
Kuwano, M ;
Kohno, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10550-10555
[13]   Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung [J].
Giaccone, G ;
vanArkOtte, J ;
Scagliotti, G ;
Capranico, G ;
vanderValk, P ;
Rubio, G ;
Dalesio, O ;
Lopez, R ;
Zunino, F ;
Walboomers, J ;
Pinedo, HM .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1264 (03) :337-346
[14]  
Goswami PC, 1996, MOL CELL BIOL, V16, P1500
[15]   DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASES-I AND TOPOISOMERASES-II DURING THE EUKARYOTIC CELL-CYCLE [J].
HECK, MMS ;
HITTELMAN, WN ;
EARNSHAW, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (04) :1086-1090
[16]   Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase II alpha promoter [J].
Herzog, CE ;
Zwelling, LA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (03) :608-612
[17]  
HICKSON ID, 1996, ANTI-CANCER DRUG, V7, P19
[18]  
HOCHHAUSER D, 1992, J BIOL CHEM, V267, P18961
[19]  
HSIANG YH, 1988, CANCER RES, V48, P3230
[20]   Regulation of the human topoisomerase II alpha gene promoter in confluence-arrested cells [J].
Isaacs, RJ ;
Harris, AL ;
Hickson, ID .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16741-16747